Derivation and validation of a new cardiovascular risk score for people with type 2 diabetes: the New Zealand Diabetes Cohort Study

Field Value
Model ID10-059-02
Model NameNew Zealand Diabetes Cohort Study - CVD, Including Antihypertensive Meds
Pubmed ID20299482
First AuthorElley
JournalDiabetes Care
Year2010
TitleDerivation and validation of a new cardiovascular risk score for people with type 2 diabetes: the New Zealand Diabetes Cohort Study
Primary Index ConditionPopulation Sample
Secondary Index ConditionDiabetes Mellitus (DM)
OutcomeMACE
Model Sample Size36127
Cohort Sample Size36127
Number of Events6479
Follow-Up DurationLong (>6 months)
AUROC0.676
Calibration Reported1
CovariatesAge in years at diagnosis; Sex (female); Previous smoker; Current smoker; HbA1c; Systolic blood pressure (mm Hg); Maori; East Asian; Pacific; Indo-Asian; Other ethnicity; Total cholesterol/HDL cholesterol ratio; Microalbuminuria; Macroalbuminuria; Duration of diabetes; Antihypertensive therapy; Antihypertensive therapy * systolic blood pressure; Intercept
Mesh TermsTo be updated
Number of Validations4

External Validations

Yes
4
0.6345
1st Author Year Sample Size AUC Calibration Relatedness
Leeuw 2014 453 0.59 Yes Related
Leeuw 2014 584 0.62 Yes Related
Robinson 2012 1829 0.649 Yes Related
Leeuw 2014 1174 0.68 Yes Distantly Related